Compare CWH & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CWH | TTRX |
|---|---|---|
| Founded | 1966 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 363.8M | 298.8M |
| IPO Year | 2016 | 2025 |
| Metric | CWH | TTRX |
|---|---|---|
| Price | $4.41 | $10.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 2 |
| Target Price | $9.62 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 2.4M | 101.8K |
| Earning Date | 10-30-2026 | 11-25-2026 |
| Dividend Yield | ★ 2.77% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.99 | N/A |
| Revenue | ★ $4,792,017,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.68 | $900.00 |
| P/E Ratio | $1.13 | ★ N/A |
| Revenue Growth | ★ 11.83 | N/A |
| 52 Week Low | $3.97 | $2.57 |
| 52 Week High | $17.15 | $16.45 |
| Indicator | CWH | TTRX |
|---|---|---|
| Relative Strength Index (RSI) | 31.67 | 42.64 |
| Support Level | $3.97 | $9.02 |
| Resistance Level | $6.95 | $11.04 |
| Average True Range (ATR) | 0.31 | 1.06 |
| MACD | 0.02 | -0.30 |
| Stochastic Oscillator | 34.01 | 11.44 |
Camping World Holdings Inc is a retailer of RVs and related products and services. The company offers RV products and services with a national network of RV dealerships, service centers and customer support centers. It operates in two reportable segments: Good Sam Services and Plans; and RV and Outdoor Retail. The majority of the revenue is derived from RV and Outdoor Retail segment that derives revenue from the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, and supplies; the sale of outdoor products, equipment, gear and supplies; and the sale of Good Sam Club memberships and co-branded credit cards.
Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.